Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Sensei Biotherapeutics Inc shares valued at $54,575 were sold by Cambrian BioPharma Inc on Dec 09 ’25. At $8.25 per share, Cambrian BioPharma Inc sold 6,612 shares. The insider’s holdings dropped to 155,142 shares worth approximately $1.66 million following the completion of this transaction.
Also, Peyer James sold 3,507 shares, netting a total of over 27,903 in proceeds. Following the sale of shares at $7.96 each, the insider now holds 155,142 shares.
Before that, Peyer James had sold 3,105 shares from its account. In a trade valued at $26,672, the 10% Owner traded Sensei Biotherapeutics Inc shares for $8.59 each. Upon closing the transaction, the insider’s holdings decreased to 3,105 shares, worth approximately $1.69 million.
Analysts at Stephens started covering the stock with ‘”an Overweight”‘ outlook in a report released in mid May. As of July 01, 2021, Berenberg has decreased its “Buy” rating to a “Hold” for SNSE. Earlier on June 29, 2021, Oppenheimer downgraded its rating. Their new recommendation was “a Perform” for SNSE stock which previously was a “an Outperform”.
Analyzing SNSE Stock Performance
On last trading session, Sensei Biotherapeutics Inc [NASDAQ: SNSE] rose 20.61% to $10.67. The stock’s lowest price that day was $8.37, but it reached a high of $10.985 in the same session. During the last five days, there has been a surge of approximately 15.85%. Over the course of the year, Sensei Biotherapeutics Inc shares have jumped approximately 11.33%. Shares of the company reached a 52-week high of $18.35 on 10/16/25 and a 52-week low of $5.00 on 03/31/25.
Support And Resistance Levels for Sensei Biotherapeutics Inc (SNSE)
According to the 24-hour chart, there is a support level at 9.03, which, if violated, would cause prices to drop to 7.39. In the upper region, resistance lies at 11.65. The next price resistance is at 12.62. RSI (Relative Strength Index) is 61.75 on the 14-day chart, showing neutral technical sentiment.
Is Sensei Biotherapeutics Inc subject to short interest?
Stocks of Sensei Biotherapeutics Inc saw a sharp rise in short interest on 2025-12-15 jumping by 33767.0 shares to 39109.0. Data from Yahoo Finance shows that the short interest on 2025-11-14 was 5342.0 shares. A jump of 86.34% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 0.33 of the overall float, the days-to-cover ratio (short ratio) jumped to 0.33.
Which companies own the most shares of Sensei Biotherapeutics Inc (SNSE)?
In terms of Sensei Biotherapeutics Inc share price expectations, FactSet research, analysts set an average price target of 5.5 in the next 12 months, down nearly -37.85% from the previous closing price of $8.85. Analysts anticipate Sensei Biotherapeutics Inc stock to reach 6 by 2026, with the lowest price target being 5. In spite of this, 3 analysts ranked Sensei Biotherapeutics Inc stock as Buy at the end of 2026. On March 01, 2021, Piper Sandler assigned a price target of “an Overweight” to the stock and initiated coverage with a $25.
